BACKGROUND:Cardiopulmonary exercise testing (CPX) in patients with systolic heart failure (HF) is important for determining HF prognosis and helping guide timing of heart transplantation. Although approximately 20% to 30% of patients with HF are obese (body mass index [BMI] >30 kg/m(2)), the impact of BMI on CPX results is not well established. The objective of this study was to assess the relationship between BMI and CPX variables, including peak oxygen uptake (VO(2)) at ventilatory threshold, oxygen pulse, and ventilation-carbon dioxide production ratio. METHODS:Consecutive patients with systolic HF (n = 2,324) enrolled in the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training trial who had baseline BMI recorded were included in this study. Subjects were divided into strata based on BMI: underweight (BMI <18.5 kg/m(2)), normal weight (BMI 18.5-24.9 kg/m(2)), overweight (BMI 25.0-29.9 kg/m(2)), obese I (BMI 30-34.9 kg/m(2)), obese II (BMI 35-39.9 kg/m(2)), and obese III (BMI > or = 40 kg/m(2)). RESULTS:Obese III, but not overweight; obese I; or obese II was associated with decreased peak VO(2) (mL kg(-1) min(-1)) compared to normal weight status. Increasing BMI category was inversely related to ventilation/carbon dioxide production (V(E)/V(CO2)) ratio (P < .0001). On multivariable analysis, BMI was a significant independent predictor of peak VO(2) (partial R(2) = 0.07, P < .0001) and V(E)/V(CO2) slope (partial R(2) = 0.03, P < .0001) in patients with chronic systolic HF. CONCLUSIONS: Body mass index is significantly associated with key CPX fitness variables in patients with HF. The influence of BMI on the prognostic value of CPX in HF requires further evaluation in longitudinal studies.
RCT Entities:
BACKGROUND: Cardiopulmonary exercise testing (CPX) in patients with systolic heart failure (HF) is important for determining HF prognosis and helping guide timing of heart transplantation. Although approximately 20% to 30% of patients with HF are obese (body mass index [BMI] >30 kg/m(2)), the impact of BMI on CPX results is not well established. The objective of this study was to assess the relationship between BMI and CPX variables, including peak oxygen uptake (VO(2)) at ventilatory threshold, oxygen pulse, and ventilation-carbon dioxide production ratio. METHODS: Consecutive patients with systolic HF (n = 2,324) enrolled in the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training trial who had baseline BMI recorded were included in this study. Subjects were divided into strata based on BMI: underweight (BMI <18.5 kg/m(2)), normal weight (BMI 18.5-24.9 kg/m(2)), overweight (BMI 25.0-29.9 kg/m(2)), obese I (BMI 30-34.9 kg/m(2)), obese II (BMI 35-39.9 kg/m(2)), and obese III (BMI > or = 40 kg/m(2)). RESULTS: Obese III, but not overweight; obese I; or obese II was associated with decreased peak VO(2) (mL kg(-1) min(-1)) compared to normal weight status. Increasing BMI category was inversely related to ventilation/carbon dioxide production (V(E)/V(CO2)) ratio (P < .0001). On multivariable analysis, BMI was a significant independent predictor of peak VO(2) (partial R(2) = 0.07, P < .0001) and V(E)/V(CO2) slope (partial R(2) = 0.03, P < .0001) in patients with chronic systolic HF. CONCLUSIONS: Body mass index is significantly associated with key CPX fitness variables in patients with HF. The influence of BMI on the prognostic value of CPX in HF requires further evaluation in longitudinal studies.
Authors: Christian Zugck; Armin Haunstetter; Carsten Krüger; Robert Kell; Dieter Schellberg; Wolfgang Kübler; Markus Haass Journal: J Am Coll Cardiol Date: 2002-05-15 Impact factor: 24.094
Authors: Mariantonietta Cicoira; Constantinos H Davos; Darrel P Francis; Wolfram Doehner; Luisa Zanolla; Lorenzo Franceschini; Massimo F Piepoli; Andrew J S Coats; Piero Zardini; Philip A Poole-Wilson; Stefan D Anker Journal: J Card Fail Date: 2004-10 Impact factor: 5.712
Authors: Gabriel E Soto; Philip Jones; William S Weintraub; Harlan M Krumholz; John A Spertus Journal: Circulation Date: 2004-07-19 Impact factor: 29.690
Authors: Paul Chase; Ross Arena; Jonathan Myers; Joshua Abella; Mary Ann Peberdy; Marco Guazzi; Daniel Bensimhon Journal: Am J Cardiol Date: 2007-12-21 Impact factor: 2.778
Authors: Satish Kenchaiah; Jane C Evans; Daniel Levy; Peter W F Wilson; Emelia J Benjamin; Martin G Larson; William B Kannel; Ramachandran S Vasan Journal: N Engl J Med Date: 2002-08-01 Impact factor: 91.245
Authors: Adam Z Banks; Robert J Mentz; Amanda Stebbins; Catherine R Mikus; Phillip J Schulte; Jerome L Fleg; Lawton S Cooper; Eric S Leifer; Dalynn T Badenhop; Steven J Keteyian; Ileana L Piña; Dalane W Kitzman; Mona Fiuzat; David J Whellan; William E Kraus; Christopher M O'Connor Journal: J Card Fail Date: 2015-12-11 Impact factor: 5.712
Authors: Tamara B Horwich; Samuel Broderick; Leway Chen; Peter A McCullough; Theresa Strzelczyk; Dalane W Kitzman; Gerald Fletcher; Robert E Safford; Gregory Ewald; Lawrence J Fine; Stephen J Ellis; Gregg C Fonarow Journal: Am J Cardiol Date: 2011-09-09 Impact factor: 2.778
Authors: Iván José Fuentes-Abolafio; Adrian Escriche-Escuder; María Rosa Bernal-López; Ricardo Gómez-Huelgas; Michele Ricci; Manuel Trinidad-Fernández; Cristina Roldán-Jiménez; José María Arjona-Caballero; Antonio Ignacio Cuesta-Vargas; Luis Miguel Pérez-Belmonte Journal: J Clin Med Date: 2022-05-10 Impact factor: 4.964
Authors: Peter Stenvinkel; Iain A Gillespie; Jamie Tunks; Janet Addison; Florian Kronenberg; Tilman B Drueke; Daniele Marcelli; Guntram Schernthaner; Kai-Uwe Eckardt; Jürgen Floege; Marc Froissart; Stefan D Anker Journal: J Am Soc Nephrol Date: 2015-11-13 Impact factor: 10.121